Clinical Research Directory
Browse clinical research sites, groups, and studies.
Detecting Liver Fibrosis in Patients At-risk
Sponsor: Helse Stavanger HF
Summary
The project will establish a research cohort (called STELIR; STEatotisk Liver-risk In Rogaland) based on a biobank with an associated health register. The purpose is to collect, store and analyze biological material and clinical data from people at risk of steatotic liver disease (fatty liver disease). The research cohort will consist of individuals who agree to participate and will be followed over many years with planned examinations/tests at baseline, after 2 years, after 5 years and every 5 years thereafter. The STELIR cohort consists of individuals between 40 and 70 years of age who have one or more of the following risk factors: Obesity, type 2 diabetes or hazardous or harmful alcohol consumption. The biological material and clinical data collected will be stored and used for research on liver-related disease risk, diagnostics and treatment.
Key Details
Gender
All
Age Range
40 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
1200
Start Date
2026-08
Completion Date
2070-12-31
Last Updated
2026-08-20
Healthy Volunteers
No
Conditions
Interventions
Routine study procedure
Routine study procedures include: Informed consent, medical history and clinical examination, structured questionnaires (lifestyle, alcohol use, metabolic risk factors), liver elastography, blood sample collection for clinical analyses and biobanking. Assessments are conducted at baseline, after 2 years, after 5 years, and subsequently every 5 years.
Locations (1)
Stavanger University Hospital
Stavanger, Norway